semaglutide and suicide Drugs like Ozempic, Wegovy Mounjaro show no link with suicide, FDA says EMA reviews drug data relating

In the study, participants with a responsive genetic score had an 82% increase in the likelihood of acheiving weight loss with a GLP-1 medication.[ref] Another study showed that GLP1 receptor variants are associated with greater weight loss on GLP-1 RA drugs.[ref] Common genetic variants in the GLP1R (GLP-1 receptor) gene impact weight and type 2 diabetes risk

BMI and Health History Typically, candidates for prescription weight loss programs have a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition, such as high blood pressure or high cholesterol

Yet, the direct impact of sweeteners on gut bacteria remains largely uncharacterized

Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice

Regarding FDA approvals , Mounjaro is primarily approved for managing type 2 diabetes , although it has shown significant weight loss in studies